entity

aggregation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about aggregation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections

30Hypotheses

19Analyses

0Outgoing

9Incoming

0Experiments

20Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

Mechanistic Proposal: Pathologic synergy: The pathologic aggregation of...

hypothesis · 3003 words

→

tau-aggregation-kinetics-4r-tauopathies

mechanism · 1102 words

→

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (9)

Source	Relation	Type	Str
TDP-43	causes	protein	1.00
TAU	involved_in	protein	0.98
TDP-43	involved_in	protein	0.95
21209826	is required (though not sufficient) for	paper	0.90
21209826	is required, though not sufficient, for	paper	0.90
11050163	is mechanistically and temporally distinct from	paper	0.90
SNCA	involved_in	protein	0.90
C-terminal truncations	accelerates	protein	0.70
21209826	is required for	paper	0.60

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P	0.858	ALS	-
Exosomal SNCA Propagation from Lysosome-Compromised Neurons	0.777	neurodegeneration	-
NRF2-Mediated Proteostatic Convergence: Shared Oxidative Str	0.700	neurodegeneration	-
VPS35 Retromer Dysfunction Creates a GCase Trafficking Bottl	0.700	neurodegeneration	-
SNCA Aggregation Hijacks the Endosomal Sorting Complex Requi	0.690	neurodegeneration	-

HSP90-Tau Disaggregation Complex Enhancement	0.634	neurodegeneration	Tau propagation mechanisms and therapeut
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Biophysical Determinants Shifting FUS/TD
m6A-dependent control of alpha-synuclein transcript fate and	0.626	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
H7: Aberrant RNA Template Switching Converts Granules to Agg	0.625	neurodegeneration	How do pathological stress granules tran
SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycl	0.621	neurodegeneration	What are the specific PTM changes in syn
Cell-state stratification is required to resolve Causal Sequ	0.612	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Cell-state stratification is required to resolve m6A RNA Mod	0.612	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-	0.600	neurodegeneration	What are the neuron-specific effects of
Aβ-induced downregulation of circPDS5B derepresses TDP-43 mR	0.595	neurodegeneration	What mechanisms drive TDP-43 pathology s
HSP90-Tau Disaggregation Complex Enhancement	0.575	Alzheimer's Disease	Tau propagation mechanisms and therapeut
TREM2-complement-amyloid axis as therapeutic target for prot	0.550	unknown	-
Glucosylceramide accumulation nucleates alpha-synuclein aggr	0.525	Parkinson's disease	GBA-Synuclein Loop Therapeutics for PD
Microbial Metabolite-Mediated α-Synuclein Disaggregation	0.511	neurodegeneration	What are the mechanisms by which gut mic
Nucleolar p21-rRNA Co-Aggregation as Irreversible Senescence	0.500	molecular biology	What is the optimal therapeutic window t
Aggregation-prone sequences trigger HSP90-dependent conforma	0.497	protein biochemistry	Do chaperones selectively recognize path
G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-	0.490	neurodegeneration	How do disease-associated mutations in G
Caspase-2/3-mediated D421 truncation generates disease-speci	0.455	neurodegeneration	Which specific post-translational modifi
Glycan-Disrupting Tau Disaggregation	0.455	neurodegeneration	Do tau-containing vesicles exhibit uniqu
GSK3β Inhibition to Prevent α-Synuclein Phosphorylation and	0.429	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
P2X7/P2Y12 Purinergic Signaling Connects Aβ Aggregation to S	0.423	neurodegeneration	How do perivascular cells specifically r
Direct cystatin C inhibition of tau aggregation	0.390	neurodegeneration	Does the cancer-cystatin-C-TREM2 pathway
J-protein co-chaperone repertoire drives ATP-independent dis	0.380	protein biochemistry	Do chaperones selectively recognize path

Mentioning Analyses (19)

Scientific analyses that reference this entity

Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Mo

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.702

m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.662

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.847

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

Which specific CSF molecular components are essential for maintaining disease-re

neurodegeneration | 2026-04-25 | 3 hypotheses Top: 0.606

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

How does N6-methyladenosine (m6A) RNA modification alter alpha-synuclein mRNA st

active · Rounds: 4 · Score: 0.67 · 2026-04-28

What is the precise causal sequence of molecular events linking TDP-43 nuclear c

active · Rounds: 4 · Score: 0.67 · 2026-04-28

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

closed · Rounds: 4 · Score: 0.33 · 2026-04-27

Investigate how microglial senescence drives ALS progression through inflammatio

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

closed · Rounds: 4 · Score: 0.60 · 2026-04-26

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

What are the mechanisms by which microglial senescence contributes to ALS pathol

closed · Rounds: 6 · Score: 0.75 · 2026-04-26

Related Research

Hypotheses and analyses mentioning aggregation in their description or question text

HSP90-Tau Disaggregation Complex Enhancement

Score: 0.634 · neurodegeneration · 2026-04-16

## Mechanistic Overview HSP90-Tau Disaggregation Complex Enhancement starts from the claim that modulating HSP90AA1 with

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetic

Score: 0.626 · neurodegeneration · 2026-04-28

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetics should produce a measurable proximal p

H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone

Score: 0.625 · neurodegeneration · 2026-04-22

## Mechanistic Overview H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone starts from the claim

SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycling at Synaptic Term

Score: 0.621 · neurodegeneration · 2026-04-16

## Mechanistic Overview SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycling at Synaptic Terminals starts fro

Cell-state stratification is required to resolve Causal Sequence of TDP-43 Nucle

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: TDP-43, ALS. Averaging across

Cell-state stratification is required to resolve m6A RNA Modification and Alpha-

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: m6A, RNA, N6-, alpha-synuclei

Perturbation-first validation should precede therapeutic claims for m6A RNA Modi

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Perturbation-first validation should precede therapeutic claims for Causal Seque

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autopha

Score: 0.600 · neurodegeneration · 2026-04-21

## Mechanistic Overview Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autophagosome-lysosome

Aβ-induced downregulation of circPDS5B derepresses TDP-43 mRNA translation in li

Score: 0.595 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex regulatory network involving circPDS5

HSP90-Tau Disaggregation Complex Enhancement

Score: 0.575 · Alzheimer's Disease · 2026-04-02

## **Molecular Mechanism and Rationale** The heat shock protein 90 (HSP90) chaperone system represents a critical cellu

Glucosylceramide accumulation nucleates alpha-synuclein aggregation via lipid ra

Score: 0.525 · Parkinson's disease · 2026-04-26

We propose that GBA deficiency-driven accumulation of glucosylceramide (GlcCer) in lysosomal membranes creates ordered l

aggregation

Understanding Entity Pages

Wiki Pages (2)

Mechanistic Proposal: Pathologic synergy: The pathologic aggregation of...

tau-aggregation-kinetics-4r-tauopathies

Outgoing (0)

Incoming (9)

Targeting Hypotheses (30)

Mentioning Analyses (19)

Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Mo

m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra

What are the mechanisms by which microglial senescence contributes to ALS pathol

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

Which specific CSF molecular components are essential for maintaining disease-re

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

How does PIKFYVE inhibition activate unconventional protein clearance via exocyt

What is the atomic-resolution structure of K280-acetylated tau and how does it t

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

Does DNAJB6 directly inhibit cross-seeding between tau, α-synuclein, and TDP-43

Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-syn

Do tau aggregates represent protective responses or primary pathogenic drivers i

What are the specific design principles for small molecules that can selectively

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

Protein aggregation cross-seeding across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases

Experiments (0)

Related Papers (0)

Debates (20)

How does N6-methyladenosine (m6A) RNA modification alter alpha-synuclein mRNA st

What is the precise causal sequence of molecular events linking TDP-43 nuclear c

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

Investigate how microglial senescence drives ALS progression through inflammatio

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

What are the mechanisms by which microglial senescence contributes to ALS pathol

Related Research

HSP90-Tau Disaggregation Complex Enhancement

RNA-binding protein condensate maturation from reversible phase separation to am

RNA-binding protein condensate maturation from reversible phase separation to am

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetic

H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone

SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycling at Synaptic Term

Cell-state stratification is required to resolve Causal Sequence of TDP-43 Nucle

Cell-state stratification is required to resolve m6A RNA Modification and Alpha-

Perturbation-first validation should precede therapeutic claims for m6A RNA Modi

Perturbation-first validation should precede therapeutic claims for Causal Seque

Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autopha

Aβ-induced downregulation of circPDS5B derepresses TDP-43 mRNA translation in li

HSP90-Tau Disaggregation Complex Enhancement

Glucosylceramide accumulation nucleates alpha-synuclein aggregation via lipid ra